产品编号:V094385
产品规格:5mg
产品价格:面议
| 标准品编号: | V094385 |
| 名称: | (S)-Valiolamine-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl] Voglibose-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl] |
| 别名: | S,3R,4S,5S)-2,3,4-tris(benzyloxy)-5-(((R)-3-(benzyloxy)-2-(((1R,2R,3S,4R,5R)-2,3,4-tris(benzyloxy)-5-((benzyloxy)methyl)-5-hydroxycyclohexyl)amino)propyl)amino)-1-((benzyloxy)methyl)cyclohexanol; |
| 分子式: | C₈₀H₈₈N₂O₁₁ |
| 分子量: | 1253.56 |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | (S)-Valiolamine-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl] Voglibose-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl] is an intermediate used in the synthesis of (S)-Valiolamine Voglibose Dihydrochloride (V094395), which is the main S-enantiomeric intermediate of Voglibose (V750000), an α-glucosidase inhibitor that works by delaying the digestion and absorption of carbohydrates, thereby inhibiting postprandial hyperglycemia and hyperinsulinemia. |
| 参考文献 | |